GORAN ANDO - 05 Jan 2024 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
05 Jan 2024
Net transactions value
$0
Form type
4
Filing time
09 Jan 2024, 20:53:55 UTC
Previous filing
22 Jun 2023
Next filing
21 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Option (Right to Buy) Award $0 +23,598 $0.000000 23,598 05 Jan 2024 Common Stock 23,598 $20.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.